Christi Hostetler

Title: Innovations by Christi Hostetler

Introduction

Christi Hostetler is a notable inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms for the drug apremilast. With a total of 3 patents to her name, her work is recognized for its innovative approach to drug formulation.

Latest Patents

One of Christi's latest patents focuses on formulations of apremilast. The patent describes oral dosage forms that include a core tablet with a drug layer comprising apremilast and hypromellose acetate succinate (HPMCAS) in an amorphous solid dispersion. Additionally, the core tablet features a swellable layer made of one or more swellable polymers, along with a coating layer that has at least one drug release orifice. These oral dosage forms are designed for once-a-day dosing of apremilast and are suitable for treating diseases or disorders that can be improved by inhibiting phosphodiesterase subtype IV (PDE4).

Career Highlights

Christi Hostetler is currently employed at Amgen Inc., a leading biotechnology company. Her work at Amgen has allowed her to focus on innovative drug formulations that enhance patient care and treatment efficacy.

Collaborations

Throughout her career, Christi has collaborated with several talented individuals, including Nathan Bennette and William Brett Caldwell. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Christi Hostetler's contributions to pharmaceutical innovations, particularly in the formulation of apremilast, highlight her expertise and dedication to improving healthcare solutions. Her work continues to impact the field positively.